Patricia LoRusso

Dr. Patricia LoRusso is an Associate Center Director for Innovative Medicine at Yale Cancer Center and a practicing academic medical oncologist performing clinical/translational research in early phase clinical trials. She currently serves on the NCI Investigational Drug Steering Committee (IDSC), having served as chair from 2011 to 2013. She also serves as the chair of the Cancer Research United Kingdom (CRUK) New Agents Committee (NAC), reviewing international proposals relative to drug development of novel agents.

Dr. LoRusso has had continuous NIH/NCI peer review funding for 28 years, having held a U-grant for early phase clinical trials through the NCI Cancer Therapy Evaluation Program (CTEP) for 26 years. She has also collaborated on numerous other grants and have been an investigator in P01 and P30 funding mechanisms. She has reviewed grants for many study sections and has either been an ad hoc (e.g. CCSG, NeXT study sections) or permanent study section member (e.g. Program Project Subcommittee D and Clinical Oncology study sections). She served a 4-year term (2015-2019) on the Board of Scientific Council (BSC), reviewing the intramural programs for quality, content, productivity and funding. In addition to serving in NCI positions, Dr. LoRusso has served in leadership positions of several other organizations. She has served on the Board of Directors and numerous scientific and education committees of the American Association for Cancer Research (AACR), the education and scientific committees of the American Society of Clinical Oncology (ASCO), and the steering committee for the Food and Drug Administration (FDA) Accelerating Anticancer Agent Development and Validation Workshop, as examples.

Prior to Yale, Dr. LoRusso spent 25 years at Wayne State University/Karmanos Cancer Institute in Detroit, MI. She earned an MD from Michigan State University, a BS in religion/religious studies & biology.